Urgent 2

profilestudystudent
lambert_chapter_13PPT.pptx

Chapter 13

Mental Illness

2

Outline

The challenge of classifying and treating mental illness

Schizophrenia

Depression

Anxiety disorders and other related disorders

Classifying and treating mental illness

Where do mental illnesses come from?

The stars, the humors, the brain?

How do disruptions in neurons propagate to severe cognitive/behavioral dysfunction?

4

Classifying and treating mental illness

Once we agree that the brain is the source of the illness, how do you fix it?

Electroconvulsive therapy (ECT)

Drugs?

Surgery?

Classifying and treating mental illness

Nobel Prize winning treatment

Although the lobotomy treatment strategy led to the Nobel Prize, it is now known that the procedure lacked empirical support and, unfortunately, resulted in severe impairment in the patients who received the “treatment.” Shown here are a set of Watts–Freeman lobotomy instruments.

6

Classifying and treating mental illness

At 12 years of age, Howard Dully was lobotomized by Dr. Walter Freeman at the request of his stepmother, who was concerned about his behavioral problems, including not cleaning his room or wanting to bathe.

7

Classifying and treating mental illness

Even today we can’t agree on how to classify mental illness

Current efforts: ICD-10, DSM-5

Problems

Changing disorder criteria

Elusive bio/behavioral markers

Similar biological bases present different symptoms

8

Schizophrenia

1% prevalence

Does this seem high or low?

Positive Symptoms

Negative Symptoms

Positive symptoms: delusions, hallucinations

Negative symptoms: diminished emotions/thought processes

9

Schizophrenia

Potential Causes

Neurochemical

Dopamine

Acetylcholine

Glutamate

Positive symptoms: delusions, hallucinations

Negative symptoms: diminished emotions/thought processes

10

Schizophrenia

Potential Causes

Neurochemical

Dopamine

Acetylcholine

Glutamate

Positive symptoms: delusions, hallucinations

Negative symptoms: diminished emotions/thought processes

11

Schizophrenia

How does chlorpromazine work?

Neuroleptic drugs such as chlorpromazine block dopamine D2 receptors.

12

Schizophrenia

anti-NMDA receptor autoimmune encephalitis

Role of glutamate in schizophrenia-like symptoms

(a) Susannah Cahalan exhibited characteristic symptoms of schizophrenia after developing anti-NMDA receptor autoimmune encephalitis. (b) When cerebrospinal fluid from patients with this disorder is applied to rat brains, antibodies for NMDA receptors occupy the hippocampus (shown in blue).

13

Schizophrenia: Anatomy

Smaller

Temporal lobes

Frontal lobes

Thalamus

More loss of gray matter during adolescence

Larger

Ventricles

In identical twins disconcordant for schizophrenia, the twin with schizophrenia has larger ventricles.

14

Schizophrenia: Anatomy

In identical twins disconcordant for schizophrenia, the twin with schizophrenia has larger ventricles.

15

Schizophrenia: Anatomy

When compared with healthy controls, individuals diagnosed with schizophrenia have altered receptors in the chandelier cells of the cortex. ese chandelier cells are thought to communicate with the cortical pyramidal cells.

16

Schizophrenia: Anatomy

In the hippocampus, pyramidal cells are characterized as being disorganized in comparison to the more organized alignment observed in healthy controls, a structural effect that likely affects neuronal processing in this brain structure.

17

Schizophrenia: Genetics

Because the highest concordance rate of schizophrenia is observed in identical twins and the lowest concordance rate in two individuals who are not related, a genetic component is acknowledged and is being investigated by researchers.

18

Schizophrenia: Environment

When individuals lived in the more urban settings at any year during the first 15 years of their lives, this variable was associated with a higher risk of schizophrenia. Additional analyses indicated that individuals living in urban settings for the entire first 15 years had the highest rates of schizophrenia.

19

Schizophrenia: Environment

Should we move out of cities?

What is it about cities that might cause/trigger schizophrenia?

When individuals lived in the more urban settings at any year during the first 15 years of their lives, this variable was associated with a higher risk of schizophrenia. Additional analyses indicated that individuals living in urban settings for the entire first 15 years had the highest rates of schizophrenia.

20

Schizophrenia: Treatment

Pharmacological treatment

Cognitive remediation

Compensatory therapy

Schizophrenia: Treatment

Pharmacological treatment

22

Schizophrenia: Treatment

Cognitive remediation & Compensatory therapy

Early reports suggest effectiveness without the side effects

Schizophrenia: Treatment

Following 10 and 15 weeks of cognitive training, this patient experienced increased activation in the le inferior frontal gyrus (slice 1) and le lateral orbital gyrus

(slice 2). Activation in these levels was closer to that of the healthy subject than observed prior to training.

24

Schizophrenia: Treatment

How can we study schizophrenia treatments in nonhumans?

Develop a model for a specific symptom/neurochemical deficit

Treat the deficit

Schizophrenia: Treatment

(a) Although the lesioned areas were similar in both trained and untrained groups, confirmed by (b) similar lesion size scores, (c) the trained animals performed similar to the non-lesioned controls in the cognitive task, with fewer entrances into a shock zone than the non-trained animals over the course of two days of trials.

26

Depression

17% lifetime prevalence

Neurochemical basis

Monoamine hypothesis

Dopamine hypothesis

Molecular hypothesis

Cortisol

BDNF

Depression: Monoamine hypothesis

Imipramine blocks the reuptake of the monoamines, thereby keeping them in the synapse longer.

28

Depression: BDNF

Comparing dendritic branches in medial prefrontal cortex in mice with low BDNF

In an investigation of the role of varying levels of BDNF on brain areas implicated in depression, mice with significantly reduced BDNF levels exhibited increased atrophy of the dendritic branches in the medial prefrontal cortex.

29

Depression: Anatomy

Symptoms suggest anatomical targets

Lank of motivation for pleasurable activities

Nucleus accumbens

Effort-based reward theory

Lack of concentration/cognitive difficulty

PFC

Chronic stress

Hippocampal volume/function

30

Depression: Network Hypothesis

Rather than a single “chemical imbalance” depression may result from a disorder of connectivity

Activity-dependent neuroplasticity

How do you measure network activity in humans?

This theoretical model proposes that depression results from compromised neural networks, and the symptoms subside when the networks are recovered through effective treatments.

31

Depression: Treatment

ECT / rTMS

Pharmacotherapy

Cognitive and behavioral therapies

Emerging treatments

32

Depression: Treatment

ECT

still used for patients that do not respond to other approaches

Some short-term effectiveness

Side effects include memory loss

rTMS

Magnetic stimulation

Less intense, fewer side effects

Data is still coming in

Depression: Treatment

Treatment with rTMS involves positioning a very powerful electromagnet on the scalp that ultimately depolarizes underlying neurons.

34

Depression: Treatment

Pharmacotherapy

MAOIs

Tricyclics

SSRIs

Need better double-blind studies

Prevalence of side effects may un-blind control vs. experimental group

Depression: Treatment

Cognitive

Focus on eliminating the destructive beliefs of the patient

Longer lasting effects

Combined drug/cognitive approaches are common

Behavioral

Focus on how the patient interacts with the external environment.

Patients learn contingency between behavior and positive outcomes (effort-based reward model)

36

Depression: Treatment

Efficacy rates of various depression therapies. At two time points, 8 weeks and 16 weeks, there is little difference between antidepressant and cognitive therapies.

37

Depression: Treatment

Deep brain stimulation

Common Targets: subcallosal cingulate gyrus, lateral habenula

Edi Guyton, after suffering from long-term depression, had electrodes implanted into the subcallosal cingulate to treat the depression symptoms

38

Depression: Treatment

Neural plasticity may underlie all treatment effects

Several common treatment strategies impact neural plasticity that restores the neural networks for competent rather than impaired function

39

Bipolar Disorder

Lows of depression

Manic periods where those with this disorder often engage in dangerous/risky behaviors.

Treatment most often lithium

Likely affects serotonin

70-80% effective

40

Anxiety Disorders

Anxiety is a feature of life, but out of control anxiety can cause severe disruptions

State vs. trait anxiety

Anxiety Disorders: Causes

Often triggered by a stressful event

Amygdala and GABA system have been implicated

Chronic stress may damage stress response system

Measureable genetic component

Don’t forget about individual differences

42

Anxiety Disorders: Causes

Genetic predispositions, environmental factors, and anxiety disorders. Exposure to the same life stressors can result in different anxiety response outcomes in individuals with varying genetic predispositions and environmental histories.

43

Anxiety Disorders: Causes

Environmental contexts, such as leaving a car in the parking lot, can prompt sufficient uncertainty and anxiety to trigger obsessions characteristic of OCD. For example, as fear and worry are experienced, this may ultimately lead to a response resulting in reduced anxiety (e.g., going back to the parking lot to make sure the car is locked).

44

Anxiety Disorders: Treatments

SSRIs

not fast acting

Surgery

bilateral lesions to the lower medial OFC and the anterior cingulate bundle area

Behavioral approaches, e.g., exposure therapy for phobias

Anxiety Disorders: Treatments

A two-hour exposure therapy session resulted in persistent decreases in self-reported phobia symptoms, self-reported fear beliefs, the ability to approach a live tarantula, and the fear associated with that fear.

46

Anxiety Disorders: Treatments

How do we get (un)learning to generalize to new contexts?

Are there any phobias for which exposure therapy might be impractical?

What about exposure in a virtual environment/video game context?

Anxiety Disorders: Treatments

After multiple context exposure (MCE) therapy in which participants are exposed to spiders in various colored room contexts or the single context exposure therapy, (b) the participants in the MCE group were able to move a live spider in a box closer to them in the behavioral approach test.

48

Anxiety Disorders

Anxieties can have adaptive value

Difficult to change behavior, when alternatives exist

e.g., Avoiding shaking hands

How do we decide when a compulsive behavior should be modified?

To avoid germ transmission and calm his anxiety, the comedian Howie Mandel greets others by tapping fists rather than shaking hands.

49

|